N-[4-(3,5-dimethyl-1,2,4-triazol-1-yl)phenyl]-4-[5-methyl-4-(1H-pyrazol-4-yl)-1,2-oxazol-3-yl]pyrimidin-2-amine
C21H19N9O — CID 117077959
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-(3,5-dimethyl-1,2,4-triazol-1-yl)phenyl]-4-[5-methyl-4-(1H-pyrazol-4-yl)-1,2-oxazol-3-yl]pyrimidin-2-amine
N-[4-(3,5-dimethyl-1,2,4-triazol-1-yl)phenyl]-4-[5-methyl-4-(1H-pyrazol-4-yl)-1,2-oxazol-3-yl]pyrimidin-2-amine (PubChem CID 117077959) has the molecular formula C21H19N9O and a molecular weight of 413.45 g/mol. Its IUPAC name is N-[4-(3,5-dimethyl-1,2,4-triazol-1-yl)phenyl]-4-[5-methyl-4-(1H-pyrazol-4-yl)-1,2-oxazol-3-yl]pyrimidin-2-amine.
Molecular Properties
| Compound Name | N-[4-(3,5-dimethyl-1,2,4-triazol-1-yl)phenyl]-4-[5-methyl-4-(1H-pyrazol-4-yl)-1,2-oxazol-3-yl]pyrimidin-2-amine |
|---|---|
| PubChem CID | 117077959 |
| Molecular Formula | C21H19N9O |
| Molecular Weight | 413.45 g/mol |
| Exact Mass | 413.17 |
| IUPAC Name | N-[4-(3,5-dimethyl-1,2,4-triazol-1-yl)phenyl]-4-[5-methyl-4-(1H-pyrazol-4-yl)-1,2-oxazol-3-yl]pyrimidin-2-amine |
| SMILES | Cc1nc(C)n(-c2ccc(Nc3nccc(-c4noc(C)c4-c4cn[nH]c4)n3)cc2)n1 |
| InChI | InChI=1S/C21H19N9O/c1-12-19(15-10-23-24-11-15)20(29-31-12)18-8-9-22-21(27-18)26-16-4-6-17(7-5-16)30-14(3)25-13(2)28-30/h4-11H,1-3H3,(H,23,24)(H,22,26,27) |
| InChIKey | ODHCQXUVXIVPKE-UHFFFAOYSA-N |
| XLogP | 3.77 |
| TPSA | 123.23 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 413.45 |
| LogP ≤ 5 | 3.77 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 117077959 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.